The conversation discusses hair loss treatments, specifically mentioning Minoxidil, finasteride, and RU58841, and highlights hairmultiplication research from Koehler Lab at Harvard. Users express optimism about future advancements.
A breakthrough in hair follicle cultivation using induced pluripotent stem cells (iPSCs) has been achieved, producing large hair follicles suitable for transplantation. Clinical trials for this hairmultiplication technology are planned in partnership with Yinguan Biotechnology.
Hairmultiplication or cloning is not available anywhere in the world. The conversation also mentions treatments like Minoxidil, finasteride, and RU58841 for hair loss.
The conversation discusses hair loss treatments, including Minoxidil, finasteride, and RU58841. It also mentions ongoing human trials for hairmultiplication/cloning at Yokohama National University, with skepticism about the timeline.
RepliCel has purchased Trichoscience, and they have a video about hairmultiplication. The conversation also mentions treatments like Minoxidil, finasteride, and RU58841.